Form4insider filings, from the source

Company · CIK 0001787400 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Nkarta, Inc. · NKTX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $4,813 · 1net −$4,813
$10k$10k$100k$100k$1M$1MbuyssalesJun 17Jun 17Jun 17Jun 18Jun 18Jun 18Jun 19

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 18, 2026 SForm 4 →Jun 22, 4:05 pm EDTPaul J HastingsChief Executive Officer, Director1,776$2.71$4,813390,247−0.45%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 10, 2026 AForm 4 →Jun 11, 4:30 pm EDTRA CAPITAL MANAGEMENT, L.P. +4Director, 10% Owner37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:27 pm EDTAli BehbahaniDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:20 pm EDTSimeon GeorgeDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:11 pm EDTGeorge VratsanosDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:08 pm EDTZachary ScheinerDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:07 pm EDTLeone D PattersonDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:07 pm EDTMichael DybbsDirector37,000——37,000—
Jun 10, 2026 AForm 4 →Jun 11, 4:06 pm EDTAngela ThedingaDirector37,000——37,000—